Avalia Immunotherapies Competitors and Similar CompaniesClear all

Avalia Immunotherapies's competitors and similar companies include Eikonoklastes Therapeutics, BioAtla, LianBio and Xilio Therapeutics.

	Avalia Immunotherapies Avalia Immunotherapies is a company that develops immune system modulators and vaccines for the treatment and prevention of infectious diseases and cancer.	Eikonoklastes Therapeutics Eikonoklastes Therapeutics is a developer of tissue factor (TF) immunotherapies for triple-negative breast cancer (TNBC) and several other diseases.	BioAtla BioAtla is a biopharmaceutical company that develops antibody-based therapeutics for the treatment of solid tumor cancer.	LianBio LianBio is a biopharmaceutical company that designs and provides innovative drugs and treatments for oncology and cardiology diseases.	Xilio Therapeutics Xilio Therapeutics (formerly Akrevia Therapeutics) is a biopharmaceutical company focused on developing targeted immuno-oncology therapeutics.
Founding Date	Founding Date 2015	Founding Date 2019	Founding Date 2007	Founding Date 2019	Founding Date 2015
Type	Type Private	Type Private	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development oncology pharma therapy	Tags Healthcare biotech oncology pharma therapy	Tags Healthcare biotech drug development oncology pharma therapy	Tags Healthcare biotech drug development oncology pharma therapy	Tags Healthcare biotech drug development oncology pharma therapy
Locations	Locations Lower Hutt, NZ HQ	Locations Cincinnati, US HQ	Locations San Diego, US HQ	Locations Princeton, US HQ Shanghai, CN	Locations Waltham, US HQ
Employees	Employees 4	Employees 8	Employees 616% decrease	Employees 87	Employees 69
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 100.8 m	Valuation ($) 34.5 m	Valuation ($) 43.5 m
Financial
Net income	Net income N/A	Net income N/A	Net income ($59.6m) (FY, 2025)	Net income ($110.3m) (FY, 2022)	Net income ($35m) (FY, 2025)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 1.1m	Total funding raised $ 186.5m	Total funding raised $ 310m	Total funding raised $ 233m